Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Omega_Pharma
|
| gptkbp:acquisitionYear |
2015
|
| gptkbp:category |
gptkb:biotechnology
gptkb:insurance |
| gptkbp:CEO |
gptkb:Patrick_Lockwood-Taylor
|
| gptkbp:founded |
1887
|
| gptkbp:founder |
gptkb:Luther_Perrigo
|
| gptkbp:headquartersLocation |
gptkb:Dublin,_Ireland
gptkb:Allegan,_Michigan,_United_States |
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:ISIN |
IE00BGH1M568
|
| gptkbp:netIncome |
$-0.29 billion (2022)
|
| gptkbp:numberOfEmployees |
~9,000
|
| gptkbp:products |
nutritional products
over-the-counter pharmaceuticals generic prescription drugs |
| gptkbp:revenue |
$4.45 billion (2022)
|
| gptkbp:servesArea |
worldwide
|
| gptkbp:stockExchange |
gptkb:New_York_Stock_Exchange
|
| gptkbp:stockSymbol |
gptkb:PRGO
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.perrigo.com/
|
| gptkbp:bfsParent |
gptkb:Joseph_C._Papa
gptkb:Jeff_Kindler gptkb:Paul_Singer |
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Perrigo
|